Literature DB >> 269683

Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy.

M A Pollack, N L Cohen, A J Friedhoff.   

Abstract

Gilles de la Tourette's syndrome was independently ascertained in two male cousins once removed. Previous studies have shown familial clustering of individuals with tics, but no consistent pattern of inheritance of Tourette's syndrome has been apparent. The onset and later exacerbation of symptoms in our younger patient were associated with the administration of CNS stimulants given for excessive motor activity. The adverse effects of methylphenidate and dextroamphetamine therapy on Tourette's syndrome supports the hypothesis that this condition results from a relative excess of CNS catecholaminergic activity. Physicians prescribing these agents should inquire about the presence of tics in patients and their families.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 269683     DOI: 10.1001/archneur.1977.00500220064011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

Review 1.  A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Martin A Katzman; Tia Sternat
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

Review 2.  Gilles de la Tourette syndrome: a review.

Authors:  M Lawden
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

3.  PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.

Authors:  N Turjanski; G V Sawle; E D Playford; R Weeks; A A Lammerstma; A J Lees; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

4.  Tourette's syndrome in a black woman with associated triple X and 9p mosaicism.

Authors:  D N Singh; G L Howe; H W Jordan; S Hara
Journal:  J Natl Med Assoc       Date:  1982-07       Impact factor: 1.798

5.  Significance of genetic factors in Gilles de la Tourette syndrome: a review.

Authors:  R S Wilson; D C Garron; H L Klawans
Journal:  Behav Genet       Date:  1978-11       Impact factor: 2.805

Review 6.  Tourette syndrome: clinical characteristics and current management strategies.

Authors:  E H Kossoff; H S Singer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

8.  Gilles de la Tourette's syndrome in monozygotic twins.

Authors:  J Waserman; S Lal; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

9.  Detection of major gene for Gilles de la Tourette syndrome.

Authors:  D E Comings; B G Comings; E J Devor; C R Cloninger
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

10.  A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems.

Authors:  D E Comings; B G Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.